603205526	603205526	CD	B-NP	O
|	|	NNP	I-NP	O
MBHMCO	MBHMCO	NNP	I-NP	O
|	|	VBD	B-VP	O
46397318	46397318	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
013431	013431	CD	B-NP	O
|	|	CC	I-NP	O
1/15/2002	1/15/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHEST	CHEST	NNP	I-NP	I-protein
PAIN	PAIN	NNP	I-NP	I-protein
,	,	,	O	O
RULE	RULE	NNP	B-NP	O
OUT	OUT	NNP	I-NP	O
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	O
INFARCTION	INFARCTION	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/14/2002	4/14/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/20/2002	7/20/2002	CD	B-NP	O
ADMITTING	ADMITTING	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
,	,	,	O	O
IN-STENT	IN-STENT	JJ	B-NP	O
RESTENOSIS	RESTENOSIS	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
LIST	LIST	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CORONARY	CORONARY	NN	B-NP	B-protein
ARTERY	ARTERY	NN	I-NP	I-protein
DISEASE	DISEASE	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

IN-STENT	IN-STENT	JJ	B-NP	O
RESTENOSIS	RESTENOSIS	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mrs.	Mrs.	NNP	B-NP	O
Segonia	Segonia	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
53-year-old	53-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
history	history	NN	I-NP	O
as	as	IN	B-PP	O
follows	follow	VBZ	B-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
2001	2001	CD	B-NP	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
at	at	IN	B-PP	O
Tormor	Tormor	NNP	B-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
,	,	,	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
RCA	RCA	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
RCA	RCA	NN	I-NP	O
.	.	.	O	O

Stents	Stent	NNS	B-NP	O
were	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
to	to	TO	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
and	and	CC	I-NP	O
mid	mid	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
August	August	NNP	B-NP	O
of	of	IN	B-PP	O
2001	2001	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
represented	represent	VBN	B-VP	O
with	with	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
in-stent	in-stent	JJ	B-NP	O
restenosis	restenosis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
angioplasty	angioplasty	JJ	B-NP	O
and	and	CC	I-NP	O
brachytherapy	brachytherapy	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
July	July	NNP	B-NP	O
of	of	IN	B-PP	O
2002	2002	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
repeat	repeat	NN	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
for	for	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
angina	angina	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
in-stent	in-stent	JJ	B-NP	O
restenosis	restenosis	NN	I-NP	O
.	.	.	O	O

Again	Again	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
angioplasty	angioplasty	NN	I-NP	O
to	to	TO	B-PP	O
zero	zero	CD	B-NP	O
percent	percent	NN	I-NP	O
.	.	.	O	O

Later	Later	RB	B-ADVP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
of	of	IN	B-PP	O
2002	2002	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
2002	2002	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
usual	usual	JJ	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
and	and	CC	O	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
I	I	CD	I-NP	O
of	of	IN	B-PP	O
0.15	0.15	CD	B-NP	O
.	.	.	O	O

MIBI	MIBI	NNP	B-NP	O
showed	show	VBD	B-VP	O
inferior	inferior	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
RCA	RCA	NN	I-NP	O
instent	instent	NN	I-NP	O
restenosis	restenosis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
PTCA	PTCA	NN	B-NP	O
without	without	IN	B-PP	O
stenting	stente	VBG	B-VP	O
.	.	.	O	O

Today	Today	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presents	present	VBZ	B-VP	O
complaining	complain	VBG	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
sharp	sharp	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
across	across	IN	B-PP	O
the	the	DT	B-NP	O
precordium	precordium	NN	I-NP	O
with	with	IN	B-PP	O
onset	onset	NN	B-NP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
with	with	IN	B-PP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
were	be	VBD	B-VP	O
intermittent	intermittent	JJ	B-ADJP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
presentation	presentation	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
10/10	10/10	CD	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
only	only	RB	I-VP	O
partially	partially	RB	I-VP	O
relieved	relieve	VBN	I-VP	O
with	with	IN	B-PP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
Vic	Vic	NNP	B-NP	O
Storgre	Storgre	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
aspirin	aspirin	NN	B-NP	O
225	225	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
sublingually	sublingually	RB	B-ADVP	O
x	x	SYM	O	O
one	one	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
x	x	SYM	B-NP	O
one	one	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
98/54	98/54	CD	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
one	one	CD	B-NP	O
bolus	bolus	NN	I-NP	O
of	of	IN	B-PP	O
heparin	heparin	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
recurrent	recurrent	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	HYPH	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
Coronary	Coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-	-	HYPH	B-NP	O
please	please	NN	I-NP	O
see	see	VBP	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
present	present	JJ	B-NP	O
illness	illness	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Hypercholesterolemia	Hypercholesterolemia	NNP	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Zestril	Zestril	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
FAMILY	FAMILY	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
father	father	NN	I-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
55	55	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
three	three	CD	B-NP	O
brothers	brother	NNS	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
sister	sister	NN	I-NP	O
who	who	WP	B-NP	O
are	be	VBP	B-VP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
never	never	RB	B-ADVP	O
a	a	DT	B-NP	O
smoker	smoker	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
divorced	divorce	VBN	I-VP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
two	two	CD	B-NP	O
sons	son	NNS	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
son	son	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
anesthesiologist	anesthesiologist	NN	I-NP	O
here	here	RB	B-ADVP	O
at	at	IN	B-PP	O
Bluass	Bluass	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
97.4	97.4	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
56	56	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
144/75	144/75	CD	I-NP	O
,	,	,	O	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
appeared	appear	VBD	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
and	and	CC	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Extraocular	Extraocular	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Oropharynx	Oropharynx	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
with	with	IN	B-PP	O
moist	moist	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
Jugular	Jugular	JJ	B-NP	O
vein	vein	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Supple	Supple	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Bradycardic	Bradycardic	JJ	B-ADJP	O
with	with	IN	B-PP	O
regular	regular	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	NNP	B-NP	O
and	and	CC	B-PP	O
without	without	IN	B-PP	O
tenderness	tenderness	NN	B-NP	O
or	or	CC	I-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NN	B-NP	O
and	and	CC	O	O
without	without	IN	B-PP	O
edema	edema	NN	B-NP	O
.	.	.	O	O

DP	DP	NN	B-NP	O
pulses	pulse	VBZ	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

NEUROLOGICAL	NEUROLOGICAL	NN	B-NP	O
:	:	:	O	O
Nonfocal	Nonfocal	JJ	B-ADJP	O
.	.	.	O	O

RECTAL	RECTAL	NN	B-NP	O
:	:	:	O	O
Guaiac	Guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
cardiopulmonary	cardiopulmonary	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NNP	B-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
2002	2002	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
normal	normal	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	B-DNA
anterior	anterior	JJ	I-NP	I-DNA
anteroseptal	anteroseptal	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
,	,	,	O	O
normal	normal	JJ	B-NP	O
RV	RV	NN	I-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
with	with	IN	B-PP	O
borderline	borderline	JJ	B-NP	O
RVH	RVH	NN	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	B-protein
MR	MR	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
trace	trace	NN	B-NP	B-protein
PR	PR	NN	I-NP	I-protein
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
143	143	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.1	4.1	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
109	109	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
25	25	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
19	19	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.0	1.0	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
106	106	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
8.9	8.9	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
5.6	5.6	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
32.4	32.4	CD	I-NP	I-protein
-LRB-	-LRB-	:	O	I-protein
baseline	baseline	NN	B-NP	I-protein
32-34	32-34	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
180	180	CD	B-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
75	75	CD	I-NP	I-protein
,	,	,	O	O
troponin	troponin	NN	B-NP	O
.02	.02	CD	I-NP	O
,	,	,	O	O
PT	PT	NN	B-NP	B-protein
14.3	14.3	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.1	1.1	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
28.3	28.3	CD	I-NP	I-protein
,	,	,	O	O
cholesterol	cholesterol	NN	B-NP	B-protein
165	165	CD	I-NP	I-protein
,	,	,	O	O
LDL	LDL	NN	B-NP	B-protein
94	94	CD	I-NP	I-protein
,	,	,	O	O
HDL	HDL	NN	B-NP	B-DNA
45	45	CD	I-NP	I-DNA
,	,	,	O	O
triglycerides	triglyceride	VBZ	B-VP	O
129	129	CD	B-NP	O
.	.	.	O	O

Electrocardiogram	Electrocardiogram	NN	B-NP	O
on	on	IN	B-PP	O
5/6/02	5/6/02	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
at	at	IN	B-PP	O
49	49	CD	B-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
T-wave	T-wave	JJ	I-NP	O
inversion	inversion	NN	I-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
lead	lead	NN	B-NP	O
III	III	CD	I-NP	O
on	on	IN	B-PP	O
3/12/02	3/12/02	CD	B-NP	O
was	be	VBD	B-VP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
5/6/02	5/6/02	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
in-stent	in-stent	JJ	I-NP	O
restenosis	restenosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RCA	RCA	NN	I-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
intervention	intervention	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Post	Post	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
,	,	,	O	O
Zestril	Zestril	NNP	B-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
intravenous	intravenous	JJ	B-NP	O
TNG	TNG	NN	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
recurrent	recurrent	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
8/11/02	8/11/02	CD	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
to	to	TO	B-VP	O
wean	wean	VB	I-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
intravenous	intravenous	JJ	I-NP	O
TNG	TNG	NN	I-NP	O
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	O
on	on	IN	B-PP	O
9/4/02	9/4/02	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
planned	plan	VBN	I-NP	O
transition	transition	NN	I-NP	O
to	to	TO	B-PP	O
p.o.	p.o.	FW	B-NP	O
Isordil	Isordil	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
again	again	RB	B-ADVP	O
had	have	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
,	,	,	O	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
restarting	restart	VBG	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
heparin	heparin	NN	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
intravenous	intravenous	JJ	B-NP	O
TNG	TNG	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
changes	change	VBZ	B-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
and	and	CC	I-NP	O
bruit	bruit	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	B-DNA
femoral	femoral	JJ	I-NP	I-DNA
artery	artery	NN	I-NP	I-DNA
catheterization	catheterization	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

Ultrasound	Ultrasound	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
groin	groin	NN	I-NP	O
on	on	IN	B-PP	O
9/4/02	9/4/02	CD	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
pseudoaneurysm	pseudoaneurysm	NN	B-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
recurrent	recurrent	JJ	B-NP	O
in-stent	in-stent	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
planning	plan	VBG	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Tia	Tia	NNP	B-NP	O
Mid	Mid	NNP	I-NP	O
-	-	HYPH	B-NP	O
Health	Health	NNP	I-NP	O
Of	Of	NNP	I-NP	O
in	in	IN	B-PP	O
Che	Che	NNP	B-NP	O
A	A	NNP	I-NP	O
Fay	Fay	NNP	I-NP	O
on	on	IN	B-PP	O
9/1/02	9/1/02	CD	B-NP	O
for	for	IN	B-PP	O
Robimycin	Robimycin	NNP	B-NP	O
coated	coat	VBD	B-VP	O
stents	stent	NNS	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Hematology	Hematology	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
unfractionated	unfractionated	JJ	I-NP	O
heparin	heparin	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
PT	PT	NN	I-NP	O
of	of	IN	B-PP	O
60-80	60-80	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
PTT	PTT	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Renal	Renal	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-NP	O
post	post	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
planned	plan	VBN	I-VP	O
to	to	TO	I-VP	O
undergo	undergo	VB	I-VP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
Foote	Foote	NNP	B-NP	O
Health	Health	NNP	I-NP	O
in	in	IN	B-PP	O
Mi	Mi	NNP	B-NP	O
for	for	IN	B-PP	O
Robimycin	Robimycin	NNP	B-NP	O
coated	coat	VBD	B-VP	O
stents	stent	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
transfer	transfer	NN	I-NP	O
will	will	MD	B-VP	O
take	take	VB	I-VP	O
place	place	NN	B-NP	O
by	by	IN	B-PP	O
ambulance	ambulance	NN	B-NP	O
on	on	IN	B-PP	O
9/1/02	9/1/02	CD	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Unfractionated	Unfractionated	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
at	at	IN	B-PP	O
900	900	CD	B-NP	B-DNA
units	unit	NNS	I-NP	I-DNA
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
,	,	,	O	O
intravenous	intravenous	JJ	B-NP	O
TNG	TNG	NN	I-NP	O
at	at	IN	B-PP	O
40	40	CD	B-NP	O
mcg	mcg	NN	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
,	,	,	O	O
enteric	enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Zestril	Zestril	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Serax	Serax	NN	B-NP	O
15-30	15-30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
insomnia	insomnia	NN	I-NP	O
,	,	,	O	O
benadryl	benadryl	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
insomnia	insomnia	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
LAB	LAB	NN	I-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
135	135	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.2	4.2	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
103	103	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
25	25	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
19	19	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	B-protein
99	99	CD	I-NP	I-protein
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9.1	9.1	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.9	1.9	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
5.7	5.7	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
33	33	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
179	179	CD	B-NP	I-protein
,	,	,	O	O
PT	PT	NN	B-NP	B-cell_line
14.5	14.5	CD	I-NP	I-cell_line
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.2	1.2	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
68.6	68.6	CD	I-NP	I-protein
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-PP	O
Grayang	Grayang	NNP	B-NP	O
Joater	Joater	NNP	I-NP	O
Long	Long	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
in	in	IN	B-PP	O
Hamp	Hamp	NNP	B-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
JAY	JAY	NNP	B-NP	O
WARNS	WARNS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
JZ13	JZ13	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
IRVING	IRVING	NNP	B-NP	O
B.	B.	NNP	I-NP	O
GIACHERIO	GIACHERIO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
VN12	VN12	NNP	I-NP	O
JM201/427004	JM201/427004	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
4271	4271	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

AGVLDZ996W	AGVLDZ996W	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
11/25/02	11/25/02	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/25/02	11/25/02	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

VALENTIN	VALENTIN	NNP	B-NP	O
H.	H.	NNP	I-NP	O
STIEG	STIEG	NNP	I-NP	O
,	,	,	O	O
PORTEHA	PORTEHA	NNP	B-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
OF	OF	IN	B-PP	O
CARDIOLOGY	CARDIOLOGY	NNP	B-NP	O
TELEPHONE	TELEPHONE	NNP	I-NP	O
626-535-0876	626-535-0876	CD	I-NP	O
*	*	SYM	O	O
VNB	VNB	NN	O	O
100-390-9702	100-390-9702	CD	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

CHESTER	CHESTER	NNP	B-NP	O
VANSISE	VANSISE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
*	*	SYM	B-VP	O
TELEPHONE	TELEPHONE	NN	B-NP	O
198-657-0082	198-657-0082	CD	I-NP	O

